Alpha Cognition Inc.

ACOG

Healthcare Biotechnology

Alpha Cognition Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.2 million.

Revenue
+267.6%
EPS
+51.2%
Free cash flow
−109.3%

Quarter to June 2026, against a year earlier

8.29 0.14 +1.72%
Market cap
$180.5M
P/E
n/m
Fwd P/E
n/m
Dividend yield
—
F-score
n/a
ROIC
−144.7%
Net debt / EBITDA
2.9×
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
10.30 11.04 11.24 0.00
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(22.92) (10.13) (16.64) (19.87)
P/B ratio
2.97 2.08 1.84 3.10
EV/Sales
7.65 6.11 4.87 0.00
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(3.15) (2.18) (2.40) (4.42)
Current Ratio
9.03 12.64 8.65 6.69
Net Debt/EBITDA
5.42 6.73 12.09 6.69
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
(13.30%) (25.14%) (18.31%) (21.51%)
Free Cash Flow Yield
(23.59%) (25.46%) (18.03%) (15.22%)
Free Cash Flow per Share
(0.59) (0.54) (0.40) (0.33)
Book value per Share
2.43 2.64 3.54 2.10
Free Cash Flow
(12.86) (11.80) (7.05) (5.36)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026